Search Results - "Carroll, P.R."

Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study by Garcia-Albeniz, X, Chan, J.M, Paciorek, A, Logan, R.W, Kenfield, S.A, Cooperberg, M.R, Carroll, P.R, Hernán, M.A

“…Abstract Background The optimal timing to start androgen deprivation therapy (ADT) in prostate cancer patients with rising prostate-specific antigen (PSA) as…”
Get full text

Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes by Hussein, A.A, Welty, C.J, Ameli, N, Cowan, J.E, Leapman, M, Porten, S.P, Shinohara, K, Carroll, P.R

“…Purpose We describe the outcomes of patients with low risk localized prostate cancer who were upgraded on a surveillance biopsy while on active surveillance…”
Get full text

Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset by Lonergan, P.E., Jeong, C.W., Washington, S.L., Herlemann, A., Carroll, P.R., Cooperberg, M.R.

Get full text

Timing of radiation after radical prostatectomy for men with prostate cancer may affect clinical outcomes by Herlemann, A., Washington, S.L., Cowan, J.E., Lonergan, P.E., Nguyen, H.G., Feng, F.Y., Carroll, P.R.

Get full text

Assessing focality of dominant tumor on serial biopsy in an active surveillance cohort - implications for focal therapy by Fasulo, V., Cowan, J.E., Washington, III S.L., Nguyen, H.G., Shinohara, K., Casale, P., Carroll, P.R.

Get full text

Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer by Lonergan, P.E., Washington, S.L., Zhao, S., Cowan, J.E., Nguyen, H.G., Shinohara, K., Cooperberg, M.R., Carroll, P.R.

Get full text

Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer by Fasulo, V., De la Calle, C.M., Cowan, J.E., Lonergan, P.E., Maggi, M., Gadzinsky, A.J., Yeoung, R.A., Saita, A., Lughezzani, G., Hurle, R., Casale, P., Cooperberg, M.R., Shinohara, K., Carroll, P.R., Nguyen, H.G.

Get full text

Clinical utility of biomarkers 4K score, SelectMDx and ExoDx with MRI for the detection of high-grade prostate cancer by Fasulo, V., De La Calle, C.M., Cowan, J.E., Herlemann, A., Chu, C.E., Gadzinsky, A.J., Yeung, R.A., Saita, A., Cooperberg, M.R., Shinohara, K., Carroll, P.R., Nguyen, H.G.

Get full text

Evaluation of the 4K score and MRI for the detection of high-grade prostate cancer by Fasulo, V., De La Calle, C.M., Cowan, J.E., Herlemann, A., Chu, C.E., Gadzinsky, A.J., Yeung, R.A., Saita, A., Cooperberg, M.R., Shinohara, K., Carroll, P.R., Nguyen, H.G.

Get full text

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial by Ferdinandus, J., Fendler, W.P., Calais, J., Eiber, M., Flavell, R.R., Mishoe, A., Feng, F.Y., Nguyen, H.G., Reiter, R.E., Rettig, M.B., Gartmann, J., Smith, R., Small, E.J., Slavik, R., Carroll, P.R., Herrmann, K., Czernin, J., Hope, T.A.

Get full text

Role of Endorectal MRI and MRSI in Defining the Dominant Intraprostatic Lesion in Prostate Cancer: Quantitative Analysis of Imaging Contour Compared to Whole-Mount Histopathology by Anwar, M.M, Westphalen, A.C, Jung, A, Noworolski, S, Kurhanewicz, J, Simko, J.P, Carroll, P.R, Coakley, F.V

Get full text

Timing of Postoperative Radiation Therapy (PORT) for Patients at High-risk of Recurrence after Radical Prostatectomy (RP): Analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Study by Hsu, C.C, Hsu, I.J, Roach, M, Paciorek, A.T, Cooperberg, M.R, Carroll, P.R

Get full text

Aspirin Use and the Risk of Prostate Cancer Death in Men Treated with Prostatectomy or Radiotherapy: Results from the CaPSURE Database by Choe, K.S, Cowan, J.E, Carroll, P.R, D'Amico, A.V, Liauw, S.L

Get full text

Clinical utility of ExosomeDx with or without multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer by Fasulo, V., De La Calle, C.M., Maggi, M., Cowan, J.E., Yeung, R.A., Shinohara, K., Buffi, N.M., Carroll, P.R., Nguyen, H.G.

Get full text

Adverse pathological findings in deferred radical prostatectomy in men under active surveillance for very low and low risk prostate cancers: Results from GAP3 active surveillance cohorts by Marenghi, C., Qiu, Z., Nicolai, N., Helleman, J., Nieboer, D., Rubio-Briones, J., Carroll, P.R., Cowan, J.E., Lee, L.S., Boutros, P.C., Valdagni, R.

Get full text

Impact of Stress Urinary Incontinence after Radical Prostatectomy on Time to Intervention, Quality of Life and Work Status by Braun, A, Washington, SL, Cowan, JE, Hampson, LA, Carroll, PR

“…To characterize the incidence of stress urinary incontinence (SUI) after radical prostatectomy (RP), its treatment, and impact on quality of life (QoL) and…”
Get full text

External validation of a model predicting increase in Gleason grade for men on Active Surveillance in the GAP3 consortium database by Nieboer, D., De Vos, I., Lee, L.S., Stricker, P., Frydenburg, M., Bjartell, A., Rubio-Briones, J., Semjonow, A., Rannikko, A., Van Hemelrijck, M., Pavlovich, C.P., Carroll, P.R., Roobol, M.J.

Get full text

Association Between Common Urologic Medications and Onset of Alzheimer's Disease and Related Dementias in Men With Prostate Cancer Managed by Different Primary Treatment Modalities by Braun, A E, Cowan, J E, Hampson, L A, Broering, J M, Suskind, A M, Carroll, P R

“…To understand the relationship between common urologic medications phosphodiesterase-5 inhibitors (PDE5i) and anticholinergics (AC) and risk of dementia onset…”
Get full text

Clinical utility of ExosomeDx with or without multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer by Fasulo, V., De La Calle, C.M., Maggi, M., Cowan, J.E., Yeung, R.A., Shinohara, K., Buffi, N., Carroll, P.R., Nguyen, H.G.

Get full text

Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies by Tretiakova, M S, Wei, W, Boyer, H D, Newcomb, L F, Hawley, S, Auman, H, Vakar-Lopez, F, McKenney, J K, Fazli, L, Simko, J, Troyer, D A, Hurtado-Coll, A, Thompson, I M, Carroll, P R, Ellis, W J, Gleave, M E, Nelson, P S, Lin, D W, True, L D, Feng, Z, Brooks, J D

“…Background: Expanding interest in and use of active surveillance for early state prostate cancer (PC) has increased need for prognostic biomarkers. Using a…”
Get full text